These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 14075642)

  • 1. FIBRINOLYSIN, FIBRIN AND HYALINE MEMBRANES.
    LIEBERMAN J; AMBRUS CM
    Pediatrics; 1963 Nov; 32():940-2. PubMed ID: 14075642
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of fibrinolysin and varidase in the hyaline membrane syndrome of the premature newborn].
    ALVAREZ de los COBOS J; JURADO GARCIA E; DULANTO GUTIERREZ E; VILLAVICENCIO L
    Rev Esp Pediatr; 1962; 18():567-78. PubMed ID: 14041022
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE USE OF FIBRINOLYSIN AND VARIDASE IN THE HYALINE MEMBRANE SYNDROME IN THE PREMATURE NEWBORN].
    ALVAREZDELOSCOBOS J; DULANTOGUTIERREZ E; JURADOGARCIA E; VILLAVICENCIO L
    Minerva Pediatr; 1964 May; 16():628-33. PubMed ID: 14169281
    [No Abstract]   [Full Text] [Related]  

  • 4. [PULMONARY HYALINE MEMBRANE. EXPERIMENTAL STUDY ON THE EFFECT OF STREPTOKINASE-STREPTODORNASE (VARIDASE) ON THE HYALINE MEMBRANE AND ON THE PULMONARY PARENCHYMA].
    ALVIZOURI M
    Neumol Cir Torax; 1963; 24():321-9. PubMed ID: 14090956
    [No Abstract]   [Full Text] [Related]  

  • 5. QUANTITATIVE ESTIMATION OF UROKINASE AND BACTERIAL PLASMINOGEN ACTIVATORS USING A FIBRIN SUBSTRATE FORMED FROM PLASMINOGEN-FREE FIBRINOGEN.
    ANDERSON AJ
    Biochim Biophys Acta; 1963 Aug; 74():554-7. PubMed ID: 14071603
    [No Abstract]   [Full Text] [Related]  

  • 6. [HYALINE MEMBRANE SYNDROME AND FIBRINOLYSIS].
    OPDECOUL AA; RUBENS A
    Ned Tijdschr Geneeskd; 1964 Mar; 108():473-5. PubMed ID: 14142099
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasminogen and plasmin. I. Studies on activation of plasminogen and on inactivation of plasmin].
    KOWALSKI E; LATALLO Z; NIEWIAROWSKI S
    Acta Biochim Pol; 1956; 3(1):87-108. PubMed ID: 13338989
    [No Abstract]   [Full Text] [Related]  

  • 8. [A CASE OF PREMATURITY WITH INTRAUTERINE BRONCHOPNEUMONIA AND PULMONARY HYALINE MEMBRANES].
    FUENTESOLANO C
    Bol Med Hosp Infant Mex; 1963; 20():713-6. PubMed ID: 14095190
    [No Abstract]   [Full Text] [Related]  

  • 9. Formation and properties of the activator of plasminogen and of human and bovine plasmin.
    MULLERTZ S
    Biochem J; 1955 Nov; 61(3):424-34. PubMed ID: 13269378
    [No Abstract]   [Full Text] [Related]  

  • 10. MOLECULAR CHANGES IN THE ACTIVATION OF PLASMINOGEN. II. COMPARISON OF PEPTIDE LIBERATION DURING INCUBATION WITH AND WITHOUT STREPTOKINASE.
    RIFE U; SHULMAN S
    Biochim Biophys Acta; 1964 May; 86():328-38. PubMed ID: 14171007
    [No Abstract]   [Full Text] [Related]  

  • 11. THE STREPTOKINASE-PLASMINOGEN SYSTEM. III. HISTOPATHOLOGY OF ENHANCED STREPTOCOCCAL VIRULENCE IN RABBIT SKIN DUE TO ACTIVATION OF THIS SYSTEM.
    JANNACH JR; KRASNER RI
    J Infect Dis; 1963; 113():77-85. PubMed ID: 14064152
    [No Abstract]   [Full Text] [Related]  

  • 12. MOLECULAR CHANGES IN THE ACTIVATION OF PLASMINOGEN. I. THE RELEASE OF PEPTIDE FRAGMENTS.
    SHULMAN S; RIFE U
    Biochim Biophys Acta; 1964 May; 86():317-27. PubMed ID: 14171006
    [No Abstract]   [Full Text] [Related]  

  • 13. THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE.
    BELLER FK; GOEBELSMANN U; DOUGLAS GW; JOHNSON A
    Obstet Gynecol; 1964 Jan; 23():12-6. PubMed ID: 14110046
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of epsilon-amino-caproic acid on prolactin-inactivating and fibrinolytic activities of streptokinase-activated plasminogen.
    HOPKINS TF; MEITES J
    Proc Soc Exp Biol Med; 1963 Apr; 112():830-2. PubMed ID: 13961684
    [No Abstract]   [Full Text] [Related]  

  • 15. EFFECT OF ANTICOAGULANT, FIBRINOLYTIC, AND ANTIFIBRINOLYTIC AGENTS ON EXPERIMENTAL HYALINE MEMBRANES.
    FUJIKURA T
    Am J Obstet Gynecol; 1964 Dec; 90():850-3. PubMed ID: 14241506
    [No Abstract]   [Full Text] [Related]  

  • 16. FRACTIONATION AND STANDARDIZATION OF PLASMA FIBRINOLYTIC COMPONENTS.
    MACKAY M
    Br Med Bull; 1964 Sep; 20():189-94. PubMed ID: 14209757
    [No Abstract]   [Full Text] [Related]  

  • 17. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
    TYLER HM; LACK CH
    Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258
    [No Abstract]   [Full Text] [Related]  

  • 18. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON INTRAVASCULAR CLOT LYSIS.
    LEWIS JH; KERBER CW; WILSON JH
    Am J Physiol; 1964 Nov; 207():1044-8. PubMed ID: 14237447
    [No Abstract]   [Full Text] [Related]  

  • 19. THE CASEINOLYTIC METHOD FOR DETERMINATION OF PLASMINOGEN-PLASMIN IN HUMAN PLASMA AND SERUM.
    JACOBSEN CD
    Scand J Clin Lab Invest; 1964; 16():372-82. PubMed ID: 14202017
    [No Abstract]   [Full Text] [Related]  

  • 20. CURRENT STATUS OF THROMBOLYTIC THERAPY.
    SHERRY S
    Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.